A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,995,495 shares of RDY stock, worth $148 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,995,495
Previous 1,929,889 3.4%
Holding current value
$148 Million
Previous $142 Million 7.4%
% of portfolio
0.27%
Previous 0.22%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$68.26 - $76.19 $4.48 Million - $5 Million
65,606 Added 3.4%
1,995,495 $152 Million
Q1 2024

May 13, 2024

BUY
$67.36 - $77.59 $4.65 Million - $5.36 Million
69,094 Added 3.71%
1,929,889 $142 Million
Q4 2023

Feb 13, 2024

BUY
$64.27 - $69.9 $1.63 Million - $1.77 Million
25,371 Added 1.38%
1,860,795 $129 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $11.6 Million - $13.7 Million
188,200 Added 11.43%
1,835,424 $123 Million
Q2 2023

Aug 11, 2023

SELL
$53.34 - $63.11 $1.47 Million - $1.74 Million
-27,600 Reduced 1.65%
1,647,224 $104 Million
Q1 2023

May 12, 2023

BUY
$51.63 - $56.93 $521,463 - $574,993
10,100 Added 0.61%
1,674,824 $95.3 Million
Q4 2022

Feb 13, 2023

SELL
$51.15 - $57.45 $5.58 Million - $6.27 Million
-109,114 Reduced 6.15%
1,664,724 $86.1 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $13.2 Million - $15.1 Million
-263,900 Reduced 12.95%
1,773,838 $92.8 Million
Q2 2022

Aug 12, 2022

BUY
$49.62 - $58.13 $6.23 Million - $7.3 Million
125,500 Added 6.56%
2,037,738 $113 Million
Q1 2022

May 13, 2022

SELL
$48.27 - $65.25 $120,675 - $163,125
-2,500 Reduced 0.13%
1,912,238 $107 Million
Q4 2021

Feb 11, 2022

SELL
$59.5 - $67.25 $4.38 Million - $4.95 Million
-73,600 Reduced 3.7%
1,914,738 $125 Million
Q3 2021

Nov 12, 2021

SELL
$60.19 - $75.29 $1.01 Million - $1.26 Million
-16,800 Reduced 0.84%
1,988,338 $130 Million
Q2 2021

Aug 13, 2021

SELL
$62.12 - $74.2 $1.99 Million - $2.37 Million
-32,000 Reduced 1.57%
2,005,138 $147 Million
Q1 2021

May 13, 2021

SELL
$57.98 - $73.08 $12.4 Million - $15.6 Million
-214,100 Reduced 9.51%
2,037,138 $125 Million
Q4 2020

Feb 10, 2021

SELL
$62.61 - $71.29 $6.96 Million - $7.92 Million
-111,100 Reduced 4.7%
2,251,238 $160 Million
Q3 2020

Nov 13, 2020

BUY
$51.39 - $72.41 $534,456 - $753,064
10,400 Added 0.44%
2,362,338 $164 Million
Q2 2020

Aug 13, 2020

BUY
$39.55 - $54.65 $14.1 Million - $19.5 Million
356,890 Added 17.89%
2,351,938 $125 Million
Q1 2020

May 14, 2020

BUY
$34.75 - $45.85 $9.94 Million - $13.1 Million
286,166 Added 16.75%
1,995,048 $80.5 Million
Q4 2019

Feb 13, 2020

BUY
$36.66 - $41.78 $8.45 Million - $9.63 Million
230,400 Added 15.58%
1,708,882 $69.3 Million
Q3 2019

Nov 13, 2019

BUY
$34.82 - $39.26 $9.75 Million - $11 Million
279,882 Added 23.35%
1,478,482 $56 Million
Q2 2019

Aug 12, 2019

BUY
$36.05 - $42.76 $4.85 Million - $5.76 Million
134,600 Added 12.65%
1,198,600 $44.9 Million
Q1 2019

May 14, 2019

BUY
$35.77 - $40.57 $1.74 Million - $1.97 Million
48,600 Added 4.79%
1,064,000 $43.1 Million
Q4 2018

Feb 13, 2019

BUY
$31.89 - $38.44 $32.4 Million - $39 Million
1,015,400 New
1,015,400 $38.3 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.3B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.